You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Amgen Inc. (AMGN $296.70)
- $296.70 P/E (TTM): 24.21X Cap: $159.73B
- View AMGN Profile
- View Questions on AMGN
Regeneron Pharmaceuticals Inc. (REGN $628.00)
- $628.00 P/E (TTM): 15.36X Cap: $66B
- View REGN Profile
- View Questions on REGN
Vertex Pharmaceuticals Incorporated (VRTX $421.67)
- $421.67 P/E (TTM): 30.19X Cap: $108.11B
- View VRTX Profile
- View Questions on VRTX
iShares Biotechnology ETF (IBB $156.08)
- $156.08 P/E (TTM): 18.89X Cap: $6.43B
- View IBB Profile
- View Questions on IBB
Mettler-Toledo International Inc. (MTD $1,420.35)
- $1,420.35 P/E (TTM): 35.67X Cap: $29.25B
- View MTD Profile
- View Questions on MTD
Solid Biosciences Inc. (SLDB $4.41)
- $4.41 Cap: $427M
- View SLDB Profile
- View Questions on SLDB
TCR2 Therapeutics Inc. (TCRR)
- Cap: $58M
- View TCRR Profile
- View Questions on TCRR
NextCure Inc. (NXTC $9.64)
- $9.64 Cap: $32M
- View NXTC Profile
- View Questions on NXTC

Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?

Read Answer Asked by Larry M. on May 11, 2022

Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use